David Champion
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
United States healthcare faces challenges in accessibility and alignment with patient needs. Leaders discuss patient-centered care and business success in a well-being economy.
Nathan Sackett, Kimberly Roddy, Le Ondra Clark Harvey, Deidra Somerville, Tyler Norris
Blake Mycoskie founded TOMS Shoes with the One for One® model, providing shoes to children in need globally. He also co-founded Madefor to promote positive habits and practices.
Joe Green, Blake Mycoskie
Visionaries in Colorado and Oregon are shaping new psychedelic eco-systems by teaching, educating, and building businesses and nonprofits. Dreams are becoming reality in these emerging landscapes.
Jamie Beachy, Steve Elfrink, Martha Hammel, Nate Howard, Meaghan Len Richmond, Barine Majewska
Indigenous communities are key to the emerging psychedelic industry but often see little benefit. How can companies ensure their inclusion and fair share in the growing market? Join the conversation.
Jeeshan Chowdhury, David Heldreth, Julia Mande
Panel: New psychedelic entrepreneurs discuss unique business structures and financial strategies aligning with values and purpose, rejecting traditional models for innovative, purpose-driven for-profit ventures.
Daniel Tarockoff, Scarlet Masius
TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.
Jeannie Moller Fontana
Key themes at Psychedelic Science 2023 included examining access, affordability, and reciprocity. The community was urged to address the impact of colonial systems on Indigenous communities and ensure equity for
Marwan and Noam, Snow Raven
Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.
Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd
Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.
Sandy Samberg